• Home
  • TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.

TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.

Author List
D'Souza J, Leung CJ, Ballapuram AC, Lin AS, Batingana AR, Lamble AJ, Ries RE, Morales CE, Cottonham C, Gona P, Fan L, Ma X, Shannon K, Meshinchi S, Braun BS, Huang BJ
Publication
bioRxiv : the preprint server for biology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/609297992
Publication Year
2025
PubMed ID
40196700
Publication Title
D'Souza J, Leung CJ, Ballapuram AC, Lin AS, Batingana AR, Lamble AJ, Ries RE, Morales CE, Cottonham C, Gona P, Fan L, Ma X, Shannon K, Meshinchi S, Braun BS, Huang BJ. TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia. bioRxiv. 2025 Mar 27.
Publication Medline TA
bioRxiv
Date
2025-03-27